Batlevi CL, Matsuki E, Brentjens RJ, Younes A. Novel immunotherapies in lymphoid malignancies. Nature reviews. Clin Oncol. 2016;13(1):25–40.
Montironi C, Muñoz-Pinedo C, Eldering E. Hematopoietic versus solid cancers and T cell dysfunction: looking for similarities and distinctions. Cancers (Basel). 2021;13(2):284.
Article PubMed CAS Google Scholar
Frey NV, Porter DL. CAR T-cells merge into the fast lane of cancer care. Am J Hematol. 2016;91(1):146–50.
Article PubMed CAS Google Scholar
Jena B, Moyes JS, Huls H, Cooper LJN. Driving CAR-Based T-Cell therapy to Success. Curr Hematol Malig Rep. 2014;9(1):50–6.
Article PubMed PubMed Central Google Scholar
Zhang Z, Wang T, Wang X, Zhang Y, Song S, Ma C. Improving the ability of CAR-T cells to hit solid tumors: challenges and strategies. Pharmacol Res. 2022;175:106036.
Article PubMed CAS Google Scholar
Majzner RG, Heitzeneder S, Mackall CL. Harnessing the Immunotherapy Revolution for the treatment of Childhood Cancers. Cancer Cell. 2017;31(4):476–85.
Article PubMed CAS Google Scholar
Majzner RG, Mackall CL. Tumor Antigen escape from CAR T-cell therapy. Cancer Discov. 2018;8(10):1219–26.
Article PubMed CAS Google Scholar
Mangal JL, Handlos JL, Esrafili A, Inamdar S, Mcmillian S, Wankhede M, Gottardi R, Acharya AP. Engineering Metabolism of Chimeric Antigen Receptor (CAR) cells for developing efficient immunotherapies. Cancers (Basel). 2021;13(5):1123.
Article PubMed CAS Google Scholar
Frigault MJ, Lee J, Basil MC, Carpenito C, Motohashi S, Scholler J, Kawalekar OU, Guedan S, Mcgettigan SE, Posey AJ, et al. Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells. Cancer Immunol Res. 2015;3(4):356–67.
Article PubMed PubMed Central CAS Google Scholar
Abramson JS, Palomba ML, Gordon LI, Lunning MA, Wang M, Arnason J, Mehta A, Purev E, Maloney DG, Andreadis C, et al. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study. Lancet. 2020;396(10254):839–52.
Nastoupil LJ, Jain MD, Feng L, Spiegel JY, Ghobadi A, Lin Y, Dahiya S, Lunning M, Lekakis L, Reagan P, et al. Standard-of-care Axicabtagene Ciloleucel for relapsed or refractory large B-Cell lymphoma: results from the US Lymphoma CAR T Consortium. J Clin Oncol. 2020;38(27):3119–28.
Article PubMed PubMed Central Google Scholar
Schultz LM, Baggott C, Prabhu S, Pacenta HL, Phillips CL, Rossoff J, Stefanski HE, Talano JA, Moskop A, Margossian SP, et al. Disease Burden affects outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia after Commercial Tisagenlecleucel: a Pediatric Real-World chimeric Antigen receptor Consortium Report. J Clin Oncol. 2022;40(9):945–55.
Article PubMed CAS Google Scholar
Fu T, Dai LJ, Wu SY, Xiao Y, Ma D, Jiang YZ, Shao ZM. Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response. J Hematol Oncol. 2021;14(1):98.
Article PubMed PubMed Central Google Scholar
Saleh K, Cheminant M, Chiron D, Burroni B, Ribrag V, Sarkozy C. Tumor Microenvironment and Immunotherapy-based approaches in Mantle Cell Lymphoma. Cancers (Basel). 2022;14(13):3229.
Article PubMed CAS Google Scholar
Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (London England). 2007;370:59–67.
Willimsky G, Blankenstein T. Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature. 2005;437:141–6.
Article PubMed CAS Google Scholar
Ciampricotti M, Vrijland K, Hau C, Pemovska T, Doornebal CW, Speksnijder EN, Wartha K, Jonkers J, de Visser KE. Development of metastatic HER2 + breast cancer is independent of the adaptive immune system. J Pathol. 2011;224(1):56–66.
Article PubMed CAS Google Scholar
Mascaux C, Angelova M, Vasaturo A, Beane J, Hijazi K, Anthoine G, Buttard B, Rothe F, Willard-Gallo K, Haller A, et al. Immune evasion before tumour invasion in early lung squamous carcinogenesis. Nature. 2019;571(7766):570–5.
Article PubMed CAS Google Scholar
Pylaeva E, Korschunow G, Spyra I, Bordbari S, Siakaeva E, Ozel I, Domnich M, Squire A, Hasenberg A, Thangavelu K, et al. During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodes. Cell Rep. 2022;40(7):111171.
Article PubMed CAS Google Scholar
Pan X, Zheng L. Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment. Cell Mol Immunol. 2020;17(9):940–53.
Article PubMed PubMed Central CAS Google Scholar
Flavahan WA, Gaskell E, Bernstein BE. Epigenetic plasticity and the hallmarks of cancer. Science. 2017;357(6348).
Kehrberg RJ, Bhyravbhatla N, Batra SK, Kumar S. Epigenetic regulation of cancer-associated fibroblast heterogeneity. Biochim Biophys Acta Rev Cancer. 2023;1878(3):188901.
Article PubMed PubMed Central CAS Google Scholar
Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541–50.
Article PubMed PubMed Central CAS Google Scholar
Davidov V, Jensen G, Mai S, Chen S, Pan P. Analyzing one cell at a TIME: analysis of myeloid cell contributions in the Tumor Immune Microenvironment. Front Immunol. 2020;11:1842.
Article PubMed PubMed Central CAS Google Scholar
Zhong F, Lin Y, Zhao L, Yang C, Ye Y, Shen Z. Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics. Br J Cancer. 2023;129(1):24–37.
Article PubMed PubMed Central CAS Google Scholar
Zhang Y, He M, Wang Y, Liao A. Modulators of the balance between M1 and M2 macrophages during pregnancy. Front Immunol. 2017;8:120.
PubMed PubMed Central Google Scholar
Tymoszuk P, Evens H, Marzola V, Wachowicz K, Wasmer MH, Datta S, Muller-Holzner E, Fiegl H, Bock G, van Rooijen N, et al. In situ proliferation contributes to accumulation of tumor-associated macrophages in spontaneous mammary tumors. Eur J Immunol. 2014;44(8):2247–62.
Article PubMed CAS Google Scholar
Lio CJ, Rao A. TET enzymes and 5hmC in adaptive and innate Immune systems. Front Immunol. 2019;10:210.
Article PubMed PubMed Central CAS Google Scholar
Morales-Nebreda L, Mclafferty FS, Singer BD. DNA methylation as a transcriptional regulator of the immune system. Transl Res. 2019;204:1–18.
Article PubMed CAS Google Scholar
Calle-Fabregat CDL, Morante-Palacios O, Ballestar E. Understanding the relevance of DNA methylation changes in Immune differentiation and disease. Genes (Basel). 2020;11(1):110.
Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575–80.
留言 (0)